不良事件报告系统
药物警戒
药物反应
不利影响
计算机科学
医学
个性化医疗
药品
药物不良反应
事件(粒子物理)
药理学
生物信息学
任务(项目管理)
生物
物理
经济
管理
量子力学
作者
Fan Yang,Fuzhong Xue,Yanchun Zhang,George Karypis
标识
DOI:10.1109/tkde.2021.3108819
摘要
The signaling of the associations between drugs and adverse drug reactions (ADRs) is a challenging task in pharmacovigilance, especially when an association is infrequent or has never previously been reported. Most existing methods for ADR signaling are based on analyzing the frequency with which drugs tend to co-occur with ADRs. In this article, we propose a kernelized multitask learning model, KEMULA, in which information is learned and transferred from the clinical data of other patients as collaborative information to rank distinct lists of ADRs for different patients. We comprehensively compare the performance of KEMULA against three baseline methods, two state-of-the-art ADR signaling methods, and two KEMULA variants. The method is tested on adverse drug event reports retrieved from the FDA Adverse Event Reporting System (FAERS), which includes 4,106,633 unique adverse drug event reports, 7,824 unique ADRs, 114 unique biotech drugs, 1,151 unique small molecule drugs, and 3,363 unique medical conditions. The experimental results demonstrate the advantages of our method and show that it not only can signal frequent ADRs but also has the power to signal infrequent ADRs that cannot be signaled by most existing methods.
科研通智能强力驱动
Strongly Powered by AbleSci AI